Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer

November 18, 2026

Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10

November 18, 2026

From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE

November 18, 2026
Facebook X (Twitter) Instagram
Trending
  • PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer
  • Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10
  • From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE
  • Samiran Tea Unveils New Product Portfolio, Including 10 Herbal Tea Blends, at Noida Office Inauguration
  • Manav’s ‘Bardic Voices: Where the Horizon Meets, the Magic Begins’ Explores Memory, Humanity, and the Search for Meaning
  • Glen Industries Limited Reports H1 FY27 Results
  • Spreading Bliss Foundation Supports Children in Orphanage
  • Not Just Another Wellness Brand: How Seltyca Is Combining Doctors, Science and Technology
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»Health»Wanhai Medical: Leading the Market with High-Quality Injection Pens
Health

Wanhai Medical: Leading the Market with High-Quality Injection Pens

Arjun SinghBy Arjun SinghApril 26, 2025No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

New Delhi [India], April 26: Amid the rising global prevalence of chronic diseases, the demand for injection pens, crucial self-administration devices, is growing at an unprecedented rate. Established for over ten years, Jiangsu Wanhai Medical Devices Co., Ltd. focuses on the research, production, and sales of various injection pen products. The company currently operates in a facility covering 12,000 square meters, with a new 36,000 square meter factory in the planning stages. With over 300 employees, including more than 50 in the R&D team and 12 in registration, Wanhai holds over 50 product patents and has received quality inspection reports from more than 30 third-party testing organizations. Its core product patents have undergone FTO searches by well-known patent agencies to ensure global sales without infringement risks. The company is capable of stable production of 90 million disposable and reusable injection pens annually. Recently, Wanhai completed a financing round with investment from a globally renowned institution. Following this funding, the company plans to expand its production base in Changzhou, aiming for an annual capacity of 400 million units with smart, automated production lines. With a vertically integrated industrial layout, high-quality products, rapid response times, and exceptional cost-performance ratio, Wanhai Medical has gained widespread recognition in both domestic and international markets. This article will delve into the secrets of Wanhai Medical’s success and showcase its exceptional capabilities.

Vertical Integration: Ensuring Quality and Efficiency from the Source

Wanhai Medical understands that to create a high-quality injection pen, it must start from the source. The company has established a complete industrial chain that encompasses mold design and manufacturing, injection molding, automated assembly, and testing, achieving a vertically integrated layout. This approach not only ensures smooth and efficient production processes but fundamentally guarantees product quality.

In mold design and manufacturing, Wanhai Medical utilizes advanced equipment such as the Japanese Makino CNC and Sodick EDM spark machines, ensuring accuracy and durability in its molds. For injection molding, the company operates nearly 70 high-end electric injection molding machines from brands like Sumitomo Demag and Sodick, along with sourcing raw materials from top global suppliers, laying a solid foundation for quality production.

On the automated assembly line, Wanhai employs fully automated assembly and testing equipment, significantly enhancing production efficiency and product stability. The company also features a Class 100,000 cleanroom, strictly adhering to dust-free operating procedures to ensure products remain uncontaminated during production, packaging, and transportation. These measures have enabled Wanhai Medical’s injection pen products to achieve high standards in accuracy, thrust, and stability.

High-Quality Products: Winning Market Reputation and Trust

High-quality products are the key to Wanhai Medical’s market reputation and trust.

Over the past decade, Wanhai Medical has consistently adhered to international standards and industry regulations, obtaining multiple authoritative certifications, including ISO 13485, CE certification, and domestic Class II medical device registration. The company is also equipped with high-precision testing equipment such as Hexagon coordinate measuring machines and Mitutoyo and Nikon image measuring instruments.

Efficient Response and Exceptional Cost-Performance Ratio: Meeting Diverse Market Demands

In today’s increasingly competitive market, efficient response and exceptional cost-performance have become crucial for companies to gain market share. With its vertically integrated industrial layout and strong production capabilities, Wanhai Medical can quickly respond to customer needs and provide customized, personalized solutions.

Additionally, through large-scale production and process optimization, the company continually reduces product costs, achieving an outstanding cost-performance ratio. This allows Wanhai Medical’s injection pen products(Insulin Pen, Semaglutide Pen, Tirzepatide Pen)to find the optimal balance between performance, cost, and service, meeting diverse market demands.

The company serves clients in over 60 countries and regions worldwide and has established long-term stable partnerships with internationally renowned enterprises such as Tonghua Dongbao and Biocon.

Production Process Standards

The production process standards can be referenced in the following quotation table:

Specifications and Models -WH-DE5

Unit Price (USD)-0.5

Production Process-

Raw Materials-Major Suppliers: Avient (USA), Celanese (USA), Polyplastics (Japan), Asahi Kasei (Japan)

Mold Processing-Main Equipment: Makino CNC (Japan), Sodick EDM spark machine (Japan), Sodick wire cut machine (Japan)

Mold Inspection

Main Equipment: Hexagon coordinate measuring machine

Injection Molding Production

Main Equipment: Sumitomo Demag (Japan), high-end imported electric injection molding machines from Sodick (Japan)

Assembly Process

Main Equipment: Intelligent fully automated assembly line

Assembly

Environment Cleanroom:

Class 100,000 cleanroom

Product Inspection

Main Equipment: Nikon image measuring instrument, high-precision analytical balances (Class 10,000 and Class 100,000)

Product Certification-

  • TUV CE Certification
  • ISO 13485 Certification
  • NMPA Class II Medical Device Registration Certificate
  • Production License and Business Filing Certificate
  • National Drug Packaging Material Registration
  • Successfully passed the FDA review process and obtained the Master File (DMF) registration number.

Remarks:

To ensure product quality and achieve global consistency standards, Wanhai Medical has implemented a vertically integrated industrial chain that encompasses mold design and manufacturing for injection pens, injection molding, automated assembly, and inspection.

Additionally, for major clients, the company has continuously reduced prices for specialized production over the past five years.

Through the tireless efforts of our team, our products have successfully passed the relevant review processes of the U.S. Food and Drug Administration (FDA) and have obtained the Master File (DMF) registration number. This achievement signifies that our products meet the stringent standards of quality, safety, and efficacy set by U.S. drug regulation.

Looking ahead, Wanhai Medical will continue to uphold the development philosophy of “customer-centric and quality-focused,” continuously innovating products, enhancing production capacity, and expanding both domestic and international markets. With its vertically integrated industrial layout, high-quality products, efficient response times, and exceptional cost-performance ratio, Wanhai Medical is confident in becoming a trusted injection pen brand for global biopharmaceutical companies and chronic disease patients, contributing further to the development of global healthcare.

Contact Information for Wanhai Medical:

Paul

luo@jswanhai.com

www.pen-injectors.com

Disclaimer: This is a sponsored article.The insights provided in this article are meant for informational purposes only. The website and its authors do not assume responsibility for any actions taken based on the information presented. Always consult your doctor before taking any step.

Health
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Arjun Singh
  • Website

Related Posts

Continued vigilance is essential to protect India’s polio-free status

November 17, 2026

Apollo Health strengthens its expansion in North India with New Clinic and National Reference Laboratory in Gurugram

November 16, 2026

Aayush Wellness Launches Himalayan Shilajit Drops as Global Shilajit Market is Projected to Reach USD 436.72 Million by 2034, Growing at 8.67% CAGR

November 16, 2026

Comments are closed.

Top Posts

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020

Final Battle – Avengers: Infinity War – Youtube

February 22, 2020
Don't Miss
Business

PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer

By Arjun SinghNovember 18, 2026

Mr. Devendra Ghalsashi brings over 24 years of experience across mutual funds, AIFs and PMS…

Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10

November 18, 2026

From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE

November 18, 2026

Samiran Tea Unveils New Product Portfolio, Including 10 Herbal Tea Blends, at Noida Office Inauguration

November 18, 2026
Most Popular

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer

November 18, 2026

Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10

November 18, 2026

From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE

November 18, 2026

Type above and press Enter to search. Press Esc to cancel.